Hyperglycemic compositions
    34.
    发明授权
    Hyperglycemic compositions 失效
    高性能组合物

    公开(公告)号:US5234906A

    公开(公告)日:1993-08-10

    申请号:US640478

    申请日:1991-01-10

    摘要: Compositions having amylin or an amylin agonist and a glucagon compound, particularly peptide compounds, for the control of glucose production in mammals are provided. The compositions are useful in the treatment of hypoglycemia, including acute hypoglycemic conditions such as those brought on by insulin overdose and the overuse of oral hypoglycemic agents.

    摘要翻译: 提供了具有胰岛淀粉样多肽或胰岛淀粉样多肽激动剂和用于控制哺乳动物葡萄糖产生的胰高血糖素化合物,特别是肽化合物的组合物。 该组合物可用于治疗低血糖症,包括急性低血糖病症,例如胰岛素过量引起的疾病和过量使用口服降糖药。

    HYPODERMIC NEEDLE ASSEMBLY HAVING A TRANSITION HUB FOR ENHANCING FLUID DYNAMICS AND MICROSPHERE INJECTABILITY
    35.
    发明申请
    HYPODERMIC NEEDLE ASSEMBLY HAVING A TRANSITION HUB FOR ENHANCING FLUID DYNAMICS AND MICROSPHERE INJECTABILITY 审中-公开
    具有用于增加流体动力学和微观注入能力的过渡管的HYPODERMIC针组件

    公开(公告)号:US20130096531A1

    公开(公告)日:2013-04-18

    申请号:US13520965

    申请日:2011-01-07

    IPC分类号: A61M5/32

    CPC分类号: A61M5/3293 A61M5/34 A61M5/343

    摘要: A hypodermic needle assembly and a method of delivering a microsphere drug. A hypodermic needle assembly includes an injection needle; an injection device; and a hub defining a cavity including a transition portion having a first end and a second end between the first end and an inlet of the injection needle and having a gradually decreasing diameter from the first end to the second end, wherein the hub is coupled between the injection needle and the injection device such that the first end is in fluidic communication with an outlet of the injection device and the second end is in fluidic communication with the inlet of the injection needle, wherein the diameter of the cavity at the first end is larger than an outlet diameter of the injection device, and wherein the diameter at the second end is substantially the same as an inlet diameter of the injection needle.

    摘要翻译: 皮下注射针组件和递送微球药物的方法。 皮下注射针组件包括注射针头; 注射装置; 以及限定腔体的轮毂,其包括过渡部分,所述过渡部分具有在所述第一端和所述注射针的入口之间的第一端和第二端,并且具有从所述第一端到所述第二端的直径逐渐减小,其中所述毂联接在 注射针和注射装置,使得第一端与注射装置的出口流体连通,并且第二端与注射针的入口流体连通,其中第一端的腔的直径为 大于注射装置的出口直径,并且其中第二端处的直径基本上与注射针的入口直径相同。

    MIXING TOOL
    36.
    发明申请
    MIXING TOOL 审中-公开
    混合工具

    公开(公告)号:US20120296309A1

    公开(公告)日:2012-11-22

    申请号:US13407518

    申请日:2012-02-28

    IPC分类号: A61J1/20

    摘要: The present invention provides devices and methods for mixing a formulation containing two or more constituents, such as a drug product and a diluent. The devices have a chamber for securing a container of the drug product. Various embodiments are presented. In one embodiment the device has two or more sides connected by a hinge, the two or more sides defining the chamber between them, and a handle for grasping and manipulating the device. In another embodiment the device has a housing with two or more side bars defining the chamber, the container being visible from outside the housing between the side bars and having a stopping element at the distal end, and a handle having two arms for grasping.

    摘要翻译: 本发明提供了用于混合含有两种或更多种成分(例如药物产品和稀释剂)的制剂的装置和方法。 这些装置具有用于固定药物产品的容器的腔室。 呈现各种实施例。 在一个实施例中,该装置具有通过铰链连接的两个或多个侧面,两个或多个侧面在它们之间限定室,以及用于抓握和操纵该装置的手柄。 在另一个实施例中,该装置具有壳体,其具有限定腔室的两个或多个侧杆,该容器从侧杆之间的壳体外部可见,并且在远端具有止动元件,以及具有两个抓握臂的手柄。